Managing the local complications of locally advanced prostate cancer

Current Urology Reports

Volumn 8, Issue 3, 2007, Pages 211-216

  Anast, Jason W ^b   Andriole, Gerald L ^b   Grubb III, Robert L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOCAPROIC ACID;

ACUTE PYELONEPHRITIS; ARTICLE; BLEEDING; CANCER SURGERY; CANCER SURVIVAL; CATHETER COMPLICATION; CYSTECTOMY; HEMATURIA; HUMAN; HYDRONEPHROSIS; ILEUS; INCONTINENCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; LASER SURGERY; LUNG EMBOLISM; MORBIDITY; NEPHROSTOMY; OBSTRUCTIVE UROPATHY; PALLIATIVE THERAPY; PELVIS ABSCESS; PELVIS EXENTERATION; PELVIS PAIN SYNDROME; PROSTATE CANCER; PROSTATIC STENT; RECTUM DISEASE; RECURRENT DISEASE; TRANSURETHRAL RESECTION; TREATMENT FAILURE; TREATMENT OUTCOME; UREMIA; URETHRA; URETHRA FISTULA; URINE RETENTION; UROLOGY; WOUND INFECTION; CANCER INVASION; DISEASE COURSE; MALE; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; REVIEW; STENT; TUMOR RECURRENCE; URETER OBSTRUCTION;

DISEASE PROGRESSION; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; STENTS; TRANSURETHRAL RESECTION OF PROSTATE; URETERAL OBSTRUCTION; URETHRA;

EID: 34248579750     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0008-6     Document Type: Article

References (24)

1. Fowler JE Jr, Bigler SA, White PC, et al.: Hormone therapy for locally advanced prostate cancer. J Urol 2002, 168:546-549.
2. Leibovici D, Lee AK, Cheung RM, et al.: Symptomatic local recurrence of prostate carcinoma after radiation therapy. Cancer 2005, 103:2060-2066.
3. Oefelein MG: Prognostic significance of obstructive uropathy in advanced prostate cancer. Urology 2004, 63:1117-1121.
4. Fleischmann JD, Catalona WJ: Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol 1985, 134:498-500.
5. Mazur AW, Thompson IM: Efficacy and morbidity of "channel" TURP. Urology 1991, 38:526-528.
6. Forman JD, Order SE, Zinreich ES, et al.: The correlation of pretreatment transurethral resection of prostatic cancer with tumor dissemination and disease-free survival: a univariate and multivariate analysis. Cancer 1986, 58:1770-1778.
7. Engelhardt PF, Riedl CR: Re: Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol 2005, 173:324-325.
8. Levine ES, Cisek VJ, Mulvihill MN, et al.: Role of transurethral resection in dissemination of cancer of prostate. Urology 1986, 28:179-183.
9. Crain DS, Amling CL, Kane CJ: Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer. J Urol 2004, 171:668-671.
10. Marszalek M, Ponholzer A, Rauchenwald M, et al.: Palliative transurethral resection of the prostate: functional outcome and impact on survival. BJU Int 2006, 99:56-59. Palliative TURP is a safe and effective procedure with minimal risk for prostate cancer dissemination.
11. Kumar SM: Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate. J Urol 2005, 173:511-513.
12. Goya N, Ishikawa N, Ito F, et al.: Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique. J Urol 1999, 162:383-386.
13. Mutaguchi K, Matsubara A, Kajiwara M, et al.: Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention. Urology 2006, 68:307-311.
14. Guazzoni G, Montorsi F, Bergamaschi F, et al.: Prostatic UroLume Wallstent for urinary retention due to advanced prostate cancer: a 1-year followup study. J Urol 1994, 152:1530-1532.
15. Yachia D, Aridogan IA: The use of a removable stent in patients with prostate cancer and obstruction. J Urol 1996, 155:1956-1958.
16. Harris MR, Speakman MJ: Nephrostomies in obstructive uropathy: how should hormone resistant prostate cancer patients be managed and can we predict who will benefit? Prostate Cancer Prostatic Dis 2006, 9:42-44.
17. Ganatra AM, Loughlin KR: The management of malignant ureteral obstruction treated with ureteral stents. J Urol 2005, 174:2125-2128.
18. Chung SY, Stein RJ, Landsittel D, et al.: 15-Year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 2004, 172:592-595.
19. Ku JH, Lee SW, Jeon HG, et al.: Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Urology 2004, 64:895-899.
20. Thompson IM, Teague JL, Mueller EJ, et al.: Intravesical alum irrigation for intractable bleeding secondary to adenocarcinoma of the prostate. J Urol 1987, 137:525-526.
21. Sato K, Tsuchiya N, Habuchi T, et al.: Total cystoprostatectomy in the treatment of locally advanced prostate carcinoma. Aktuelle Urol 2003, 34:259-261.
22. Leibovici D, Kamat AM, Pettaway CA, et al.: Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer. J Urol 2005, 174:2186-2190. Retrospective study demonstrating a significant and durable improvement in symptoms in patients receiving palliative cystoprostatectomy for locally advanced T4 prostate cancer.
23. Kamat AM, Huang SF, Bermejo CE, et al.: Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol 2003, 170:1868-1871.
24. Leibovici D, Pagliaro L, Rosser CJ, et al.: Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy. J Urol 2005, 173:781-783.